February 22, 2018 /10:20 AM / NSE
This is to notify the General Public that the Board of Directors of GlaxoSmithKline Consumer Nigeria plc will meet on Thursday 8th March 2018 to consider and approve:
1. The 2017 Audited Financial Statements
2. The amount to be recommended to members as dividend at the next Annual General Meeting and
3. Fix the date and venue of the Annual General Meeting.
The General Public will be informed of the Board's decisions immediately after the meeting.
The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons shall commence from Wednesday 21st February 2018 and shall terminate 24 hours after release of the result to the Nigerian Stock Exchange.